In collaboration with AusBiotech and BioMelbourne Network, mRNA Victoria is seeking Victorian-based companies with relevant experience in mRNA or RNA-related manufacture, supply chain and systems support to submit their expression of interest (EOI) for its Industry Panel.
The Industry Panel will meet as required and support mRNA Victoria, including the Scientific Advisory Group, and provide advice to mRNA Victoria on mRNA manufacturing capability and related technologies.
mRNA Victoria is a newly-established initiative and is responsible for the Victorian Government’s commitment to establish a world-class Victorian mRNA and RNA industry by supporting supply chain and R&D for pre and clinical research, commercialisation and manufacturing investments.
mRNA Victoria identifies key capabilities, gaps and opportunities and leads the engagement and partnership with domestic and international companies, researchers and stakeholders on behalf of the Victorian Government, to build RNA capability and supply chain through a suite of investments and programmes.
Alongside providing grants and international market-entry support, it will facilitate and enter into research agreements and partnerships, and deliver programmes to support the development and commercialisation of mRNA research products.
In performing these functions, mRNA Victoria is advised by a Scientific Advisory Group made up of world-leading experts from the medical research sector and is also staffed with experts in medical research and pharmaceutical manufacturing.
Register your expressions of interest here by Thursday 8 July 2021.
Registrants may be contacted and asked to provide further information once the initial EOI has been submitted.